Artificial Intelligence (AI) technology researchers from multiple institutions including the Institute of Structural Biology, Technical University of Munich, and others have developed a novel approach to drug discovery, named MISATO. This innovative model is designed to enhance the process of drug design, a critical aspect within the broader field of computational chemistry and structural biology.…